TCL Archive Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation By Cancer History Project April 28, 2006
TCL Archive Advocacy Groups Consider Pros And Cons Of Forming Co-Pay Foundations. By Cancer History Project April 28, 2006
TCL Archive WHI Update: No Increased Risk Of Cancer With Estrogen-Alone By Cancer History Project April 28, 2006
TCL Archive Panitumumab Improves PFS In Metastatic Colon Cancer By Cancer History Project April 28, 2006
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. By Cancer History Project April 21, 2006
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. By Cancer History Project April 21, 2006
Article How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer By Cancer History Project